CASP4 and non-small cell lung carcinoma: However, Terlizzi et al. (2018) found that CASP4 overexpression was associated with poor prognosis in patients with non-small cell lung cancer; in fact, CASP4 was defined as a new biomarker for the diagnosis and prognosis of non-small cell lung cancer.